Success Stories: EB-1A Petition Approved for Indian Research Scientist with 160 Citations in the Field of Pharmacology
i
Client’s Testimonial:
“Thank you for the wonderful news!! I really appreciate your work in getting my package together.”
On September 29th, 2017, we received another EB-1A (Alien of Extraordinary Ability) approval for a Research Scientist in the Field of Pharmacology (Approval Notice).
General Field: Pharmacology
Position at the Time of Case Filing: Research Scientist
Country of Origin: India
Service Center: Nebraska Service Center (NSC)
State of Residence at the Time of Filing: Indiana
Approval Notice Date: September 29th, 2017
Processing Time: 9 months, 15 days (Premium Processing Upgrade Requested)
Case Summary:
With a Ph.D. in Pharmaceutics and many years of experience conducting insightful research, there is no doubt that our client possesses the ability to continue progressing the field of pharmacology. When he approached us to build and file an EB-1A (Alien of Extraordinary Ability) petition on his behalf, we looked at more than just his doctoral degree before agreeing to take on his case. After evaluating his credentials, we confirmed that we could lead him to EB1A victory and proceeded to countersign the retainer agreement.
In preparing our client’s EB1A petition, these are some of the key points we chose to focus on:
- We noted the 160 times his work was cited by dependent and independent researchers. This indicated the major significance of his findings to other pharmacologists around the world.
- We also detailed the 16 times our client published scientific articles, all of which appeared in well-known journals.
- Further, we list the impressive 40 times our client assessed the work of his fellow peers. As only the best in the field are invited to judge the work of others, our client’s notable peer review record spoke volumes of his respected status as an extraordinary researcher.
- Arguably one of the most important elements of our client’s EB1A petition dossier was related to his research on the factors that affect the formation and stability of amorphous pharmaceutical compounds. After careful analysis, we concluded that our client’s efforts address some of the country’s most pressing issues related to the properties of pharmaceuticals, most notably in the development of safe and effective drugs to treat diseases.
- To further fortify our client’s petition, we included recommendation letters signed by several other experts in the field, one of whom stated that “[Client] is an exceptionally skilled researcher working in the area of pharmaceutics, with a particular emphasis on applying techniques of physical chemistry to better understand the physicochemical properties of pharmaceutical compounds.”